Elsevier

Ophthalmology

Volume 102, Issue 12, December 1995, Pages 1760-1769
Ophthalmology

Outcomes of Trabeculectomy for Primary Open-angle Glaucoma*

https://doi.org/10.1016/S0161-6420(95)30796-8Get rights and content

Abstract

Purpose: To determine the long-term functional and structural outcomes in patients treated with trabeculectomy for primary open-angle glaucoma.

Methods: Records of 78 consecutive patients (78 eyes) who had their first trabeculectomy were studied retrospectively (duration of follow-up, 25 to 112 months). Serial automated perimetry and stereoscopic optic disc photographs were used to assess the long-term efficacy of trabeculectomy to prevent progressive glaucomatous damage. Stereoscopic optic disc photographs were available for 29 eyes (38%). Criteria for intraocular pressure control were a minimum intraocular pressure reduction of 20% and intraocular pressure at or below 20 mmHg.

Results: There was no evidence of progression of glaucomatous damage in 81 and 65% of the eyes after 3 and 6 years, respectively. The visual field deteriorated in 16 eyes (21 %) and progressive structural optic nerve damage occurred in 4 eyes (5%) during follow-up. Deterioration of the optic nerve head in the absence of visual field progression was detected in three (4%) of those eyes. In 19 eyes (25%), further glaucoma surgery was performed. The probability of successfulintraocular pressure control after a single operation was 48% and 40% at 3 and 5 years, respectively.

Conclusion: Progressive glaucomatous damage occurs in about one third of eyes with moderate to severe primary open-angle glaucoma over a 6-year follow-up after trabeculectomy.

References (46)

  • RJ Boeglin et al.

    Long-term fluctuation of the visual field in glaucoma

    Am J Ophthalmol

    (1992)
  • M Weitzman et al.

    High resolution central visual field to detect progressive glaucomatous damage

  • K Koryllos

    Trabeculectomy: a new glaucoma operation

    Bulletin de la Societé Hellénique d'Ophtalmologie

    (1967)
  • Three-year follow-up of the Fluorouracil Filtering Surgery Study

    Am J Ophthalmol

    (1993)
  • C-W Chen et al.

    Enhancement of IOP control effect of trabeculectomy by local application of anticancer drug

  • HD Hoskins et al.

    Management of failing filtering blebs with the argon laser

    Ophthalmic Surg

    (1984)
  • J Freedman et al.

    Trabeculectomy in a black American glaucoma population

    Br J Ophthalmol

    (1976)
  • R David et al.

    Comparative study of Watson's and Cairns's trabeculectomies in a black population with open angle glaucoma

    Br J Ophthalmol

    (1977)
  • T Jerndal et al.

    330 consecutive trabeculectomies: a follow-up study through 1/2-3 years

    Acta Ophthalmol

    (1977)
  • P Wilson

    Trabeculectomy: long-term follow-up

    Br J Ophthalmol

    (1977)
  • CP Thommy et al.

    Trabeculectomy in Nigerian patients with open-angle glaucoma

    Br J Ophthalmol

    (1979)
  • KB Mills

    Trabeculectomy: a retrospective long-term follow-up of 444 cases

    Br J Ophthalmol

    (1981)
  • Cited by (146)

    • Needle Revision of Filtration Blebs

      2018, Advances in Ophthalmology and Optometry
      Citation Excerpt :

      In addition, with time, perhaps because of multiple limited instances of inflammation, the scarring process continues, eventually resulting in limitation to flow and higher intraocular pressures. Late failure to control intraocular pressure can occur in 50% [4] or more of patients following glaucoma filtration surgery [4,5]. To address the rate of initial failure, multiple approaches have been made.

    • Full-length myocilin protein is purified from mammalian cells as a dimer

      2018, Protein Expression and Purification
      Citation Excerpt :

      This high IOP many not be lowered sufficiently by current IOP-lowering medications thus, requiring these patients to have IOP-lowering surgery. IOP-lowering surgeries are prone to failure [19], so these young patients will require numerous such surgeries during their lifetime. Despite intensive research efforts, the function of wild-type (wt) MYOC remains unknown and how mutant MYOC contributes to glaucoma disease pathology is ambiguous [20,21].

    View all citing articles on Scopus
    *

    Presented at the American Academy of Ophthalmology Annual Meeting, San Francisco, November 1994.

    View full text